Real world experience with sacubitril/valsartan in heart failure

被引：0
|
作者：
Lim, E. L. S. [1 ]
Abdullah, E. L. [1 ]
Loh, L. C. W. [1 ]
Chong, P. F. [2 ]
Sia, H. P. [2 ]
Sothivadivel, S. [1 ]
Lee, J. L. [1 ]
机构：
[1] Hosp Sungai Buloh, Dept Med, Sungai Buloh, Malaysia
[2] Hosp Sungai Buloh, Dept Pharm, Sungai Buloh, Malaysia
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2024年 / 417卷
关键词：
D O I：
10.1016/j.ijcard.2024.132852
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
90
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Real world experience of sacubitril and valsartan in patients with heart failure with reduced ejection fraction
    Ganesananthan, S.
    Shah, N.
    Shah, P.
    Phillips, J.
    Elsayed, H.
    Yousef, Z.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 222 - 222
  • [2] Sacubitril/Valsartan in real world heart failure proctice in Asia
    Chu, P. H.
    Hsia, F. C.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 412 - 412
  • [3] Use of sacubitril-valsartan in heart failure with reduced ejection fraction: real world experience
    Ferreira, F. A. C.
    Cristina, S.
    Raposo, A. F.
    Albuquerque, E. M.
    Nabais, I.
    Matias, C. S.
    Nogueira, M. A.
    Vasconcellos, R. C. A.
    Proenca, G. M. M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 228 - 229
  • [4] Impact of sacubitril/valsartan on implantable defibrillator eligibility in heart failure: a real-world experience
    Monzo, L.
    Gaudio, C.
    Cicogna, F.
    Tota, C.
    Petronilli, V
    Mennuni, S.
    De Ruvo, E.
    Calo, L.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (18) : 5690 - 5700
  • [5] Sacubitril/valsartan in chronic symptomatic heart failure: a real world experience of delivery and outcomes.
    Kearney, A. Aileen
    Hill, L.
    Davidson, J.
    Mc Clure, C.
    Dixon, L.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 411 - 411
  • [6] THE USE OF SACUBITRIL/VALSARTAN: A REAL WORLD EXPERIENCE IN A HIGH VOLUME SPECIALIST HEART FAILURE SERVICE
    Murray, G.
    Barrett, M.
    Earls, S.
    Hammond, M.
    Campbell, P.
    O'Hanlon, R.
    McDonald, K.
    HEART, 2017, 103 : A8 - A9
  • [7] Impact of sacubitril/valsartan on implantable defibrillator eligibility in heart failure: a real-world experience
    Monzo, Luca
    Ferrari, Ilaria
    Gaudio, Carlo
    Cicogna, Francesco
    Tota, Claudia
    Petronilli, Valentina
    Mennuni, Silvia
    De Ruvo, Ermenegildo
    Calo, Leonardo
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0G)
  • [8] Impact of sacubitril/valsartan on implantable defibrillator eligibility in heart failure: a real-world experience
    Monzo, L.
    Cicogna, F.
    Tota, C.
    Petronilli, V.
    Mennuni, S.
    De Ruvo, E.
    Calo, L.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 42 - 43
  • [9] Impact of sacubitril/valsartan on implantable defibrillator eligibility in heart failure: a real-world experience
    Monzo, Luca
    Ferrari, Ilaria
    Gaudio, Carlo
    Cicogna, Francesco
    Tota, Claudia
    Petronilli, Valentina
    Mennuni, Silvia
    Ruvo, Ermenegildo De
    Calo, Leonardo
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (SUPPL G)
  • [10] The benefits of sacubitril/valsartan in the treatment of patients with heart failure: a real-world, single centre experience
    Celli, Valdisa
    Tari, Ylenia
    Ansani, Katia
    Bernardini, Livio
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2020, 22 (0N) : N90 - N90
12345